We are studying whether norfloxacin can lower portal hypertension in patients with decompensated cirrhosis. The trial also looks at its effects on liver-related complications and overall patient well-being.
Health conditions and diseases that the clinical trial is designed to study and treat.
Portal Hypertension is a condition characterized by increased blood pressure in the portal vein, which carries blood from the digestive organs to the liver. This can lead to serious complications, including varices and liver dysfunction.
Decompensated Cirrhosis is a severe stage of liver disease where the liver can no longer perform its normal functions, leading to symptoms like jaundice, fluid retention, and confusion. It often requires urgent medical attention.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.